Search or

𝛼SK

ENTITY

Medigen Biotechnology (3176 TT)

Health Care • Taiwan

Medigen Biotechnology Corp. researches and develops anti-cancer biopharmaceuticals.

more

Refresh

Exchange Announcement • 09 Dec 2025 17:47

Announcement Of Important Resolution By The Board Of Directors Of Subsidiary Medic Vision Ai Limited

Exchange Announcement • 25 Nov 2025 18:23

The Progress Update Of The New Drug Under Development, Obp-301

Exchange Announcement • 21 Nov 2025 06:40

Obp-301, The New Drug Under Development, Receives Preliminary Orphan Drug Designation Approval From Japan Mhlw

Exchange Announcement • 10 Nov 2025 18:32

Announcement Of Board Meeting Approved The Consolidated Financial Statements 2025q3

Exchange Announcement • 31 Oct 2025 16:21

Announcement Of The Date Of The Board Of Directors Meeting For The Third Quarter Of 2025 Financial Report

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.9

x